|
Market Closed -
Euronext Paris
00:55:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 79.74 EUR | +4.71% |
|
+7.58% | -3.60% |
| 10-31 | Sanofi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 10-31 | Sanofi Revised Earning Guidance for the Fiscal Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 107B | |||||
| 1,263B | |||||
| 658B | |||||
| 521B | |||||
| 391B | |||||
| 369B |
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
